cobas c 513 analyzer

Setting a new precedent in HbA1c lab efficiency

Product image for cobas c 513 analyzer
Do you have any questions?
Contact us

Fully automated and highly efficient workflow

The analyzer offers a fully automated and highly efficient workflow by delivering up to 400 HbA1c patient results per hour, yet requiring minimized operator intervention from sample registration to result delivery. Its closed tube sampling function delivers maximum safety to the operator.

 

Roche Tina-quant® HbA1c Gen. 3

 

The cobas c 513 analyzer runs Roche’s established Tina-quant® HbA1c Gen. 3 test which is standardized according to IFCC and transferable to DCCT/NGSP in order to ensure high quality and standardized results. With no interference by most known HbA1c variants, Roche’s Tina-quant HbA1c assay delivers accurate risk identification, diagnosis and monitors the level of HbA1c delivering results that clinicians and patients can trust.1

 

Manages high HbA1c workload

 

  • Up to 400 HbA1c patient results/hour

 

Fully automated and highly efficient workflow

 

  • Minimized operator intervention from sample registration to result delivery
  • Closed tube sampling delivers maximum safety to the operator
  • No need for sample pre-mixing

 

Result reliability

 

  • Standardized according to IFCC and transferable to DCCT/NGSP
  • Delivers risk identification, diagnosis and monitors the level of HbA1c

 

Analyzer

 

  • High throughput of up to 400 HbA1c patient results/hour 
  • Test capacity of >14,000 determinations on board 
  • Closed tube sampling 
  • Proven and trusted cobas® technology 
  • cobas link for remote services

 

Reagents

 

  • Ready to use cobas c pack large (500 tests)
  • Tina-quant® HbA1c Gen. 3 
  • Standardized according to IFCC ­transferable to DCCT/NGSP
  • Direct result reporting (in IFCC and NGSP units)

Assay menu

View full List

Assay menu

Featured Product
New Product
Featured Product
New Product

References

 

  1. Data on file. Roche Diagnostics International Ltd.